Skip to search formSkip to main contentSkip to account menu

Panretin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have… 
Highly Cited
2002
Highly Cited
2002
Objective To assess the efficacy, safety and tolerance of oral 9-cis- retinoic acid in HIV-infected patients with Kaposi's… 
Review
2001
Review
2001
  • J. Rhoads
  • Journal of the Association of Nurses in AIDS Care
  • 2001
  • Corpus ID: 33652425
1999
1999
  • The Oncologist
  • 1999
  • Corpus ID: 41917399
Highly Cited
1999
Highly Cited
1999
BACKGROUND Kaposi's sarcoma (KS) is the most frequent malignancy in patients with HIV. Given the promise that retinoids show in… 
1999
1999
  • Research initiative, treatment action : RITA
  • 1999
  • Corpus ID: 26360749
The Food and Drug Administration (FDA) recently enacted rules requiring drug companies to provide physicians with information… 
1998
1998
  • GMHC treatment issues : the Gay Men's Health…
  • 1998
  • Corpus ID: 44376153
Ligand Pharmaceuticals is seeking the Food and Drug Administration's (FDA) approval of Panretin gel (9-cis retinoic acid) to…